227 related articles for article (PubMed ID: 32377747)
1. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma.
Ervolino De Oliveira C; Dourado MR; Sawazaki-Calone Í; Costa De Medeiros M; Rossa Júnior C; De Karla Cervigne N; Esquiche León J; Lambert D; Salo T; Graner E; Coletta RD
Int J Oncol; 2020 Jul; 57(1):364-376. PubMed ID: 32377747
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of activin A in oral squamous cell carcinoma: association with poor prognosis and tumor progression.
Chang KP; Kao HK; Liang Y; Cheng MH; Chang YL; Liu SC; Lin YC; Ko TY; Lee YS; Tsai CL; Wang TH; Hao SP; Tsai CN
Ann Surg Oncol; 2010 Jul; 17(7):1945-56. PubMed ID: 20309641
[TBL] [Abstract][Full Text] [Related]
3. Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
Bufalino A; Cervigne NK; de Oliveira CE; Fonseca FP; Rodrigues PC; Macedo CC; Sobral LM; Miguel MC; Lopes MA; Paes Leme AF; Lambert DW; Salo TA; Kowalski LP; Graner E; Coletta RD
PLoS One; 2015; 10(8):e0136599. PubMed ID: 26317418
[TBL] [Abstract][Full Text] [Related]
4. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
[TBL] [Abstract][Full Text] [Related]
5. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
[TBL] [Abstract][Full Text] [Related]
6. RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma.
Zhou WN; Du YF; Bai J; Song XM; Zheng Y; Yuan H; Zhang W; Zhang ZD; Wu YN
Oncol Rep; 2017 Oct; 38(4):2378-2386. PubMed ID: 28765934
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
8. Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins: a preliminary study.
Sales CB; Buim ME; de Souza RO; de Faro Valverde L; Mathias Machado MC; Reis MG; Soares FA; Ramos EA; Gurgel Rocha CA
J Oral Pathol Med; 2016 Aug; 45(7):481-5. PubMed ID: 26861159
[TBL] [Abstract][Full Text] [Related]
9. Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells.
Tsai CN; Tsai CL; Yi JS; Kao HK; Huang Y; Wang CI; Lee YS; Chang KP
Sci Rep; 2019 Mar; 9(1):5197. PubMed ID: 30914776
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin 4A restricts tumor progression by inhibiting angiogenesis of oral squamous cell carcinoma cells.
Liu XQ; Yao Y; Mu JW; Yang FY
Tissue Cell; 2021 Apr; 69():101485. PubMed ID: 33460983
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance and Roles in Angiogenesis of Circulating Microparticles in Oral Cancer.
Ren JG; Zhang W; Liu B; Man QW; Xiong XP; Li C; Zhu JY; Wang WM; Jia J; Sun ZJ; Zhang WF; Chen G; Zhao YF
J Dent Res; 2016 Jul; 95(8):860-7. PubMed ID: 27013642
[TBL] [Abstract][Full Text] [Related]
12. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.
Wang H; Wang L; Zhou X; Luo X; Liu K; Jiang E; Chen Y; Shao Z; Shang Z
Biomed Res Int; 2020; 2020():2125656. PubMed ID: 32695810
[TBL] [Abstract][Full Text] [Related]
13. Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer.
Kaneda H; Arao T; Matsumoto K; De Velasco MA; Tamura D; Aomatsu K; Kudo K; Sakai K; Nagai T; Fujita Y; Tanaka K; Yanagihara K; Yamada Y; Okamoto I; Nakagawa K; Nishio K
Br J Cancer; 2011 Oct; 105(8):1210-7. PubMed ID: 21897392
[TBL] [Abstract][Full Text] [Related]
14. PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma.
Peterle GT; Maia LL; Trivilin LO; de Oliveira MM; Dos Santos JG; Mendes SO; Stur E; Agostini LP; Rocha LA; Moysés RA; Cury PM; Nunes FD; Louro ID; Dos Santos M; da Silva AMÁ
J Oral Pathol Med; 2018 Jul; 47(6):566-574. PubMed ID: 29693741
[TBL] [Abstract][Full Text] [Related]
15. Microvesicles releasing by oral cancer cells enhance endothelial cell angiogenesis via Shh/RhoA signaling pathway.
Huaitong X; Yuanyong F; Yueqin T; Peng Z; Wei S; Kai S
Cancer Biol Ther; 2017 Oct; 18(10):783-791. PubMed ID: 28886265
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of SUV39H1 reduces tumor angiogenesis via Notch1 in oral squamous cell carcinoma.
Chen Y; Weng X; Zhang C; Wang S; Wu X; Cheng B
PeerJ; 2024; 12():e17222. PubMed ID: 38650654
[TBL] [Abstract][Full Text] [Related]
17. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
Ji L; Zhu ZN; He CJ; Shen X
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lymphatic vessel density in oral squamous cell carcinoma.
Chen J; Zhang F; Hua M; Song X; Liu S; Dong Z
Life Sci; 2021 Jan; 265():118746. PubMed ID: 33181177
[TBL] [Abstract][Full Text] [Related]
19. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
[TBL] [Abstract][Full Text] [Related]
20. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
Ungefroren H; Hyder A; Hinz H; Groth S; Lange H; El-Sayed KM; Ehnert S; Nüssler AK; Fändrich F; Gieseler F
PLoS One; 2015; 10(2):e0118097. PubMed ID: 25707005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
